Main Street Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.26K Hold
10
﹤0.01% 639
2026
Q1
$5.62K Buy
+10
New +$6.41K ﹤0.01% 614
2025
Q4
Sell
-10
Closed -$6.39K 332
2025
Q3
$6.39K Hold
10
﹤0.01% 579
2025
Q2
$5.36K Sell
10
-10
-50% -$4.78K ﹤0.01% 570
2025
Q1
$8.4K Hold
20
﹤0.01% 521
2024
Q4
$8.27K Hold
20
﹤0.01% 515
2024
Q3
$10.1K Hold
20
﹤0.01% 492
2024
Q2
$9.53K Hold
20
﹤0.01% 524
2024
Q1
$10.6K Hold
20
﹤0.01% 530
2023
Q4
$11.1K Buy
+20
New +$9.39K ﹤0.01% 770

Other funds holding IDXX

Main Street Group's IDXX Position: Q2 2026 in Review

Main Street Group held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 10 shares worth $5.26K. The position accounts for ﹤0.01% of the portfolio, ranked #639.

Main Street Group first reported a position in IDXX in Q4 2023 and has held it in 10 quarters since. The position peaked at $11.1K in Q4 2023. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Main Street Group held 10 shares of Idexx Laboratories worth $5.26K as of Q2 2026.
  • Main Street Group left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Main Street Group's portfolio in Q2 2026, its #639 holding.
  • Main Street Group first reported a position in Idexx Laboratories in Q4 2023 and has held it in 10 quarters since.
  • Main Street Group's Idexx Laboratories position peaked at $11.1K in Q4 2023.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.